Sign in to view content

Defining and Addressing Wet AMD Non-responders

Rishi P. Singh, MD

Video
Published 2019

Related

Real World Experience of Brolucizumab for Persistent Macular Fluid in Neovascular Age-Related Macular Degeneration After Prior Anti-VEGF Treatments
Rehan M. Hussain, MD
Annual Meeting Talks
2021
Phase 3 Randomized, Double-Masked Studies of Brolucizumab Versus Aflibercept in nAMD: Expanded Primary and Secondary Outcomes From HAWK/HARRIER
Arshad M. Khanani, MD, MA, FASRS
Annual Meeting Talks
2018
Inflammation After Aflibercept Injection in Association With a Specific Brand of Syringe That Releases Silicone Oil Droplets A Case-Control Study
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2018

Category: AMD-Neovascular

See more